These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 22245332)
1. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography. Ren H; Park KC; Pan R; Waltzer WC; Shroyer KR; Pan Y J Urol; 2012 Mar; 187(3):1063-70. PubMed ID: 22245332 [TBL] [Abstract][Full Text] [Related]
2. Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography. Ren H; Yuan Z; Waltzer W; Shroyer K; Pan Y J Urol; 2010 Oct; 184(4):1499-506. PubMed ID: 20723922 [TBL] [Abstract][Full Text] [Related]
3. New optical imaging technologies for bladder cancer: considerations and perspectives. Liu JJ; Droller MJ; Liao JC J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model. Wang ZG; Durand DB; Schoenberg M; Pan YT J Urol; 2005 Dec; 174(6):2376-81. PubMed ID: 16280851 [TBL] [Abstract][Full Text] [Related]
5. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778 [TBL] [Abstract][Full Text] [Related]
6. High magnification cystoscopy in the primary diagnosis of bladder tumors. Jichlinski P; Lovisa B Curr Opin Urol; 2011 Sep; 21(5):398-402. PubMed ID: 21730856 [TBL] [Abstract][Full Text] [Related]
7. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder. Schmidbauer J; Remzi M; Klatte T; Waldert M; Mauermann J; Susani M; Marberger M Eur Urol; 2009 Dec; 56(6):914-9. PubMed ID: 19674831 [TBL] [Abstract][Full Text] [Related]
9. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ; J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291 [TBL] [Abstract][Full Text] [Related]
10. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. Lee CS; Yoon CY; Witjes JA BJU Int; 2008 Nov; 102(9 Pt B):1228-33. PubMed ID: 19035886 [TBL] [Abstract][Full Text] [Related]
11. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971 [TBL] [Abstract][Full Text] [Related]
12. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ; J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283 [TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Goh AC; Tresser NJ; Shen SS; Lerner SP Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789 [TBL] [Abstract][Full Text] [Related]
14. Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy? Karl A; Tritschler S; Stanislaus P; Gratzke C; Tilki D; Strittmatter F; Knüchel R; Stief CG; Zaak D BJU Int; 2009 Feb; 103(4):484-7. PubMed ID: 18793301 [TBL] [Abstract][Full Text] [Related]
15. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M; J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861 [TBL] [Abstract][Full Text] [Related]
16. New imaging techniques for nonmuscle invasive bladder cancer. von Rundstedt FC; Lerner SP Curr Opin Urol; 2014 Sep; 24(5):532-9. PubMed ID: 25051025 [TBL] [Abstract][Full Text] [Related]
17. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder. Chen G; Wang B; Li H; Ma X; Shi T; Zhang X Urol Oncol; 2013 May; 31(4):475-9. PubMed ID: 22079940 [TBL] [Abstract][Full Text] [Related]
18. The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer. Naselli A; Hurle R; Puppo P Expert Rev Anticancer Ther; 2012 Dec; 12(12):1523-8. PubMed ID: 23253218 [TBL] [Abstract][Full Text] [Related]
19. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. Herr HW; Donat SM BJU Int; 2008 Nov; 102(9):1111-4. PubMed ID: 18778359 [TBL] [Abstract][Full Text] [Related]
20. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]